Apple News In Conversation cover image

Why a 25-cent pill is being sold to cancer patients for nearly $1,000

Apple News In Conversation

00:00

Intro

This chapter explores the journey of a multiple myeloma patient from initial symptoms to diagnosis and treatment. It highlights the disparity between the low production cost of the drug Revlimid and its high retail price, questioning the ethics of pharmaceutical pricing for vital medications.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app